SHANGHAI JUNSHI BIOSCIENCES CO LTD.
 
 
 
 
公司概覽
業務類別 --
業務概覽 Shanghai Junshi Biosciences Co Ltd is mainly engaged in innovation-driven biopharmaceutical business. The company's main products include teriprizumab injection, Etesevimab, adalimumab injection, and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases, and infectious diseases. The group's operations are mainly located in the PRC and the United States of America.
公司地址 No. 987 Cai Lun Road, Level 4, Pilot Free Trade Zone, Shanghai, CHN
電話號碼 +86 2161058800
傳真號碼 +86 2180164691
公司網頁 https://www.junshipharma.com
員工數量 2578
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Xin Li Executive Director and the Senior Vice President, Government Affairs -- 25/04/2025
Dr. Sheng Yao Director and Deputy General Manager -- 25/04/2025
Mr. Cong Li Director and Co-Chief Executive Officer -- 25/04/2025
Mr. Zhuobing Zhang Director and Deputy General Manager -- 25/04/2025
Dr. Jianjun Zou Director, Chief Executive Officer and General Manager -- 25/04/2025
Dr. Gang Wang Director, Deputy General Manager and Chief Quality officer -- 25/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Xin Li Executive Director and the Senior Vice President, Government Affairs 25/04/2025
Mr. Zhongxian Li Independent Director 25/04/2025
Mr. Chun Zhang Independent Director 25/04/2025
Dr. Sheng Yao Director and Deputy General Manager 25/04/2025
Mr. Yi Tang Director 25/04/2025
Mr. Cong Li Director and Co-Chief Executive Officer 25/04/2025
Mr. Zhuobing Zhang Director and Deputy General Manager 25/04/2025
Mr. Jun Xiong Executive Chairman of the Board 25/04/2025
Dr. Xiaoyuan Feng Independent Director 25/04/2025
Dr. Jianjun Zou Director, Chief Executive Officer and General Manager 25/04/2025
Dr. Ning Li Vice Chairman of the Board 25/04/2025
Ms. Kun Lu Independent Director 25/04/2025
Dr. Yue Yang Independent Director 25/04/2025
Dr. Gang Wang Director, Deputy General Manager and Chief Quality officer 25/04/2025
 
所屬ETF (更新日期: 07/03/2026 04:32)
代號 名稱 佔比% 持有日期
FEMFirst Trust Emerging Mrkts AlphaDEX® ETF0.06%26/02/2026
VEUVanguard FTSE All-Wld ex-US ETF0.04%31/01/2026
SCHESchwab Emerging Markets Equity ETF™0.02%28/02/2026
VTVanguard Total World Stock ETF0.01%31/01/2026
VSGXVanguard ESG International Stock ETF0.004%31/01/2026
FLCHFranklin FTSE China ETF0.002%28/02/2026
BBEMJPMorgan BetaBuilders Emerging Mkt EqETF0.001%27/02/2026
GXCState Street® SPDR® S&P® China ETF0.001%27/02/2026
EMCRXtrackers EM CarbReduc&ClimtImprvs ETF0.0003%24/02/2026
GSEEGoldman Sachs MarketBeta Emer Mkt Eq ETF0.0002%24/02/2026
FLAXFranklin FTSE Asia ex Japan ETF0.0001%28/02/2026
BKEMBNY Mellon Emerging Markets Equity ETF0.0001%24/02/2026
EEMOInvesco S&P Emerging Markets Mom ETF0.0001%27/02/2026
FCAFirst Trust China AlphaDEX® ETF<0.000001%13/01/2026
GXUSGoldman Sachs MarketBeta(R) Ttl IntEqETF<0.000001%05/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.